FMR1 and fragile X syndrome: We demonstrate significant dose-related reduction in EEG gamma power and amelioration of inter-trial phase coherence (ITPC) deficits to temporally modulated auditory stimuli by single dose racemic baclofen in Fmr1 KO mice, and corresponding reduction in gamma power following single-dose RBAC in humans with FXS.